Ibritumomab tiuxetan [206181-63-7]

TargetMol Chemicals

Ibritumomab tiuxetan [206181-63-7]

16

Ibritumomab tiuxetan is an immunoconjugate consisting of the murine IgG1kappa anti-CD20 monoclonal antibody Ibritumomab, covalently linked to the chelator Tiuxetan, enabling the incorporation of the short-lived beta-emitter radioisotope yttrium-90. It is utilized in the research of non-Hodgkins B-cell lymphomas [1] [2].

-20°C

12352203